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Background: There has been a significant growth in the prevalence of allergy, mainly associated to IgE-mediated
disorders such as asthma and rhinitis. The identification of atopy in asthmatic patients through the measurement of
specific IgE can help to identify risk factors that cause asthmatic symptoms in patients. The development and use
of individualized allergen-based tests by the Component Resolved Diagnosis has been a crucial advance in the
accurate diagnosis and control of allergic patients. The objective of this work was to assess the usefulness of
molecular diagnosis to identify environmental allergens as possible factors influencing the development and
manifestation of asthma in a group of asthmatic patients from Iran.
Methods: Studied population: 202 adult asthmatic patients treated at the Loghman Hakim Hospital and Pasteur
Institute of Teheran (Iran) from 2011 to 2012. Specific IgE determined by the ImmunoCAP system were used to
both evaluate the patients’ atopic condition and the molecules involved in the allergic sensitization. SDS-PAGE
IgE-immunoblotting associated with mass spectrometry was carried out to study the cockroach IgE-binding
sensitizing proteins.
Results: Forty-five percent of all patients could be considered atopic individuals. Eighty-two percent of atopic
patients were sensitized to pollen allergens. The Salsola kali (Sal k 1) and the Phleum pratense (rPhl p 1 and/or rPhl
p 5) major allergens were the most common sensitizers among pollens (71% and 18%, respectively). Thirty-five
percent of the atopic population was sensitized to cockroach. Four different allergens, including a previously unknown
alpha-amylase, were identified in the cockroach extract. No significant associations could be demonstrated between
the severity of asthma and the specific IgE levels in the atopic population. Statistical analysis identified the Sal k 1 as the
main protein allergen influencing the development and expression of asthma in the studied population.
Conclusions: Pollen and cockroach were the most relevant allergen sources in the asthmatic population. The
Salsola kali major allergen was the main cause for sensitization in the atopic patients suffering asthma. Using the
Component Resolved Diagnosis, it was possible to identify a new Blattella germanica cockroach allergen (Blattella
alpha amylase 53 kDa) that could sensitize a relevant percentage of this population.
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The World Allergy Organization defines the term atopy
as a personal and/or familiar tendency to become sensi-
tized and produce IgE antibodies in response to ordinary
exposure to allergens, most frequently proteins. Common
allergens associated with atopy are inhaled and food pro-
teins [1]. There has been a significant exponential growth
in the prevalence of atopy, including IgE-mediated allergic
diseases such as asthma and rhinitis. It is estimated that
30% of the world population is now affected by one or
more allergic conditions and is capable of developing
specific IgE antibodies to different allergenic proteins
from various sources, including pollens, molds, dust
mites, insects, epithelia and foods [2].
Asthma is a worldwide problem, with an estimated
300 million affected individuals. The global prevalence
of asthma ranges from 1-18% of the population, depending
on the country. Indoor and outdoor allergens are import-
ant environmental factors that influence the development
and expression of asthma. The identification of atopy
through specific IgE determination can help to identify
the triggers able to develop symptoms of allergic asthma
in atopic patients [3]. Geographical variation in the
prevalence of sensitization to common aeroallergens is
commonly observed across different geographical sources
[4] and several studies have reported on the aeroallergen
sensitivity of Iranian patients with asthma or rhinitis [5-7]
demonstrating significant variation in sensitization sources
depending on the report. Despite the different localiza-
tions of these studies, all results agree that pollen
sensitization is the most prevalent and that Chenopodia-
ceae, grass and sycamore are the most important aller-
genic sources. The arthropods most commonly associated
with sensitization were house dust mite and cockroach,
but their prevalence was very different according to their
location.
The development and use of individualized native and/
or recombinant allergen-based tests in the routine diagno-
sis of allergic diseases have been crucial advances in the
accurate diagnosis and control of allergic patients [8]. This
advance enables the progression from mere taxonomic
diagnostic approximations to the molecular classification
of allergenic substances [9] and, thus, from individualized
allergens to clinical decisions [10]. Component Resolved
Diagnosis (CRD) has been shown to be the most accurate
methodology for the molecular diagnosis of allergy [3],
and the use of this methodology would redefine con-
cepts such as major allergens, cross-reactivity or pri-
mary sensitization [11-13]. The proteomics underlying
CRD enables a more complete description of the mo-
lecular allergen panel, independent of the availability or
knowledge of the allergen molecules involved [14].
With this in mind, the objective of this work was to dem-
onstrate which environmental allergenic proteins could bethe possible triggers of asthma in a population of atopic in-
dividuals suffering asthma symptoms in the north of Iran.
To the best of our knowledge, this is the first report to
demonstrate the prevalence of aeroallergens in asthmatic
patients from Iran evaluated by CRD.
Methods
Study population
Two hundred and two adult patients (aged 18–83 years,
mean = 41 years) treated at the Loghman Hakim Hospital
and Pasteur Institute of Teheran (Iran) from 2011 to 2012
were included in this study.
All these patients were diagnosed with asthma following
the Global Initiative for Asthma criteria [15]. Respiratory
symptoms (cough, dyspnea or chest tightness), spirometry
measurements with and without bronchodilator, and
methacholine tests (in normal pulmonary function test
cases) were performed. Only those patients who were
positive for methacholine or pulmonary function tests
were selected for inclusion in the study. Oral informed
and written consent for participating in this study was
obtained from the patients. The study was approval by
the Ethics Committee of the Loghman Hakim Hospital.
The sex distribution was 40.1% (81) male and 59.9%
(121) female.
Atopy study
Atopy for all subjects was analyzed using the Immuno-
CAP Phadiatop (ThermoFisher Sci. USA) assay [16],
which is a solid-phase immunoassay for serum specific
IgE against a balanced mixture of relevant inhaled and
food allergens. The recommendations of the manufacturer’s
protocol were strictly followed. Phadiatop ImmunoCAP
results are displayed as qualitative positive or negative
responses. Because Salsola allergen is not included in
the ImmunoCAP Phadiatop, specific IgE to this allergen
(Sal k 1) was measured for all subjects separately in an
ImmunoCAP-specific IgE assay (ThermoFisher Sci).
Specific IgE quantification
Specific IgE to allergens was quantified by the ImmunoCAP-
specific IgE assay (ThermoFisher Sci. USA) following
the recommendations of the manufacturer’s protocol.
ImmunoCAP-specific IgE results are expressed in kU/L.
Values ≤ 0.1 kU/L were considered negative results.
Specific IgE to allergen extracts from cockroach (Blattella
germanica) was used because the difficulty in obtaining
commercially available cockroach allergens.
Component resolved diagnosis
Quantitative CRD was performed in the atopic subjects
using ImmunoCAP technology (ThermoFisher Sci. USA)
following the manufacturer’s instructions. The results are
expressed in kU/L, and values ≤0.1 kU/L were considered
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rDer p 1, rDer p 2, rDer p 10, rPen a 1, rPhl p 1, rPhl p 5,
rPhl p 7, rPhl p 12, nOle e 1, nSal k 1, nArt v 1, rFel d 1,
rAlt a 1, rAsp f 1, r Asp f 6 and Aspergillus oryzae alpha
amylase.Identification of Blattella germanica allergens
Cockroach extract
Cockroach crude extract was obtained from Bial Labora-
tories (Bial-Aristegui, Bilbao, Spain).SDS-PAGE-IgE-Immunoblotting
Sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) was performed on a 4% stacking
gel and 12.5% resolving gel according to the method of
Laemmli [17]. After protein separation, gels were either
fixed and stained for crude protein using Coomassie
Brilliant Blue R-250 or transferred to a polyvinylidene
fluoride (PVDF) membrane [18]. The PVDF membrane
was incubated overnight with the patient’s sera at 4°C.
Bound IgE antibodies were detected using HRP-conjugated
goat anti-human IgE and an ECL-Western blotting kit
(Amersham ECL Plus Western Blotting Detection System,
GE Healthcare UK Ltd, Buckinghamshire, UK) [19].Table 1 Allergy diagnosis based on the allergen
components
Allergen Mean sIgE (kU/L) SD Percentage (%)
Sal k 1 26.7 18.1 71
Phl p1+ 5 7.64 10.8 18
Fel d 1 6.43 5.8 10.8
Ole e 1 2.9 3.3 7.6
Art v 1 1.4 1.3 7.6
Mean specific IgE values, standard deviation (SD) and percentage (%) of
sensitized patients to each allergen in the atopic population (n = 92).Mass spectrometry and database searching
The IgE-binding bands revealed by immunoblotting
were sent to the Proteomic Unit of Carlos III National
Centre for Cardiovascular Disease Research Foundation
(Madrid, Spain) for identification by MALDITOF-MS/
MS. MALDI-MS and MS/MS data were combined using
the BioTools programme (Bruker Daltonics, Billerica, MA,
USA) to search protein databases (NCBInr; ~4.8 × 106
entries; National Centre for Biotechnology Information,
Bethesda, MD, USA; SwissProt; ~2.6 × 105 entries; Swiss
Institute for Bioinformatics, Switzerland) using Mascot
software (Matrix Science, London, UK). MALDI-MS/
MS spectra and database search results were manually
inspected in detail using the above programs as well as
homemade software and the Structural Database of Aller-
genic Proteins. The amino acid sequence was assessed by
searching the NCBInr database with fragment ion masses
from the precursor ion at m/z = 2710.286. Protein scores
greater than 81 were considered significant (P < 0.5).
According to the Structural Database of Allergenic
Protein (SDAP), possible cross-reactivity between a
query protein and a known allergen has to be considered
when there is an identification of six contiguous amino
acids between the query sequence and any allergen [20].
The alpha-amylase amino acid sequence was assessed
by searching the SDAP in this manner, following the
database instructions.Statistical analysis
The data obtained were analyzed with GraphPad Prism
4.0 (La Jolla, CA. USA). Data are expressed as the mean
and 95% confidence interval (CI). Means were compared
using ANOVA. P values <0.05 were considered statisti-
cally significant. Logistic regression (SPSS Statistics 21.
IBM) was used to assess the association between the
quantification of major allergen-specific IgE and the
severity of asthma.
Results
Ninety-two subjects (45%) from the total evaluated sam-
ple (202 asthmatic patients) tested positive for Phadiatop
and specific IgE to Salsola kali. All these individuals
were considered atopic. Among the 202 patients studied,
57% presented with severe asthma, 36% with moderate
asthma and 7% with mild asthma. The distribution of
asthma severity among the atopic patients within the
sample was 49% for severe asthma, 38% for moderate
asthma and 13% for mild asthma. No statistically signifi-
cant differences were found between the asthmatic popu-
lation and the asthmatic population with atopy (p > 0.05).
Table 1 displays the results of the allergy diagnosis
based on the CRD concept. Eighty- two percent of
atopic patients were sensitized to pollen allergens, with
Salsola kali major allergen (Sal k 1) as the most fre-
quent allergenic source, which was able to sensitize 71%
of the atopic subjects and was associated with higher
specific IgE values (26.7 ± 21.0 kU/L). Taking into ac-
count the prevalence of sensitization to each allergen in
the atopic population, the statistical analysis demon-
strated that Sal k 1 was the primary sensitizing allergen
in the asthmatic population, showing significant differences
when compared with the remaining allergens studied
(p ≤ 0.0001).
Thirty-five percent of the atopic subjects had anti-
cockroach IgE responses, but the level of specific IgE was
lower (2.8 kU/L ± 7). Major allergens from grass pollen
(Phl p 1 + 5) showed a sensitization frequency of 18% and
a specific IgE mean value of 7.64 ± 10.8 kU/L. Eighty-eight
atopic patients (95%) were sensitized to pollens and/or
cockroach allergens.
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for other major allergens, such as Fel d 1 (6.43 kU/L ± 5.8),
Ole e 1 (2.9 kU/L ± 3.3) and Art v 1 (1.4 kU/L ± 1.3), the
sensitization rates were less than 15%. The remaining sensi-
tizing allergen components (Alt a 1, Asp f 1, Asp f 6, Phl
p 7 + 12, Der p 1, Der p 2, and tropomyosin) showed no
significant specific IgE values (mean values ≤0.5 kU/L) or
important frequencies (values less than 10%). Sensitization
by cross-reactive allergens (pollen polcalcins/profilins
and tropomyosin) reached 5.4% of atopic individuals
(5 patients), with allergen-specific mean values ranging
from 0.4 to 0.5 kU/L.
Table 2 depicts the results of a statistical analysis of
the association between asthma severity and the levels of
specific IgE in the atopic population. No significant asso-
ciations were observed.
To identify which cockroach allergens were able to
sensitize the atopic population, SDS-PAGE immunoblot-
ting associated with MALDI-TOF-MS and MALDI-TOF-
MS/MS were performed. Figure 1 shows the allergogram
of the 22 from 33 atopic patients sensitized to cockroach
crude extracts. Four IgE-binding components of 75.0,
53.0, 42.0 and 36.0 kDa molecular weight (MW), reactive
in 63.6%, 86.4%, 72.7% and 54.5% of cockroach-sensitized
patients, respectively, were revealed in this way. The
prevalence rates of each uncovered cockroach allergen
(75, 53, 42 and 36 kDa) in the total atopic population with
asthma were 15%, 20%, 17% and 12%, respectively. Mass
spectrometry analysis of the four bands allowed for the
identification of only the 53 and 42 kDa proteins. Table 3
displays the results of mass spectrometry. These two pro-
teins were identified as alpha-amylase and arginine-kinase,
which have theoretical MWs of 57.5 and 40.1 kDa, re-
spectively. No specific IgE to Aspergillus oryzae alpha-
amylase was found in sera from 8 patients sensitized to
Blattella germanica alpha-amylase (≤0.1 kU/L). A BLAST
alignment of protein sequences of Blattella germanica
alpha-amylase with Aspergillus oryzae alpha amylase
showed a query cover and E-value of 50% and 4E-12, re-
spectively. An SDAP search revealed that there was a
match of at least of six contiguous amino acids between the
alpha-amylase of Blattella germanica and the alpha-amylase
of Blomia tropicalis (Blo t 4.0101), DermatophagoidesTable 2 Statistic analysis of the association between the
severity of asthma and the level of specific IgE to the
individual allergens in the atopic population
Allergen Odds ratio P value % 95 CI
Sal k 1 1.071 0.516 0.870-1.319
Cockroach 0.992 0.969 0.673-1.462
Phl p 1 + 5 1.185 0.517 0.709-1.982
Fel d 1 0.934 0.824 0.511-1.707
Ole e 1 1.002 0.997 0.423-2.372pteronyssinus (Der p 4) and Euroglyphus maynei (Eur m 4),
which are three described mite allergens.
Discussion
Asthma is a common worldwide health problem with a
high global prevalence ranging from 1-18% of the popu-
lation depending on the country. Its association with ele-
vated total serum IgE and with allergic sensitization to
local aeroallergens has been well documented [21,22].
Indoor and outdoor allergens are important environ-
mental factors influencing the development and expres-
sion of asthma, and the measurement of specific IgE can
better define an individual’s atopic condition [23].
Several studies have demonstrated that the prevalence
of atopy is varied among asthmatic patients. Arbes et al.
[24] have reported that approximately 50% of the
current asthma cases in the US population are attribut-
able to atopy, whereas Sunyer et al. [25] have found that
the overall attributable fraction of asthma symptoms
caused by atopy in Europe is 30%, although varying
widely between centres, from 4% to 61%. In our study,
the prevalence of atopy in the asthmatic population was
of 45%. Despite the prevalence, the variability was wide,
and considering the possible role of environmental aller-
gens as a trigger of asthma development, the attributable
fraction of asthma symptoms related to atopy in the
population studied in this work agreed with the results
found by the European studies. Vernon et al. [26] have
reported that the most cited triggers of asthma are very
similar across countries/regions and included allergens
(particularly pollens, moulds, dust and pet dander), to-
bacco, exercise, air pollutants/particulates, weather pat-
terns/changes and respiratory diseases. They concluded
that a global checklist should be used in research and
clinical practice. Despite this similarity in asthma trig-
gers, the geographical differences in the sensitization to
environmental aeroallergens [27] and in the allergen
sources (fungi, plants and animals) distributed across
each region [28] make the study of allergen distribution
necessary in each area.
Component Resolved Diagnosis [11-13] has been
shown to be a more accurate methodology for the diag-
nosis of allergy, allowing for a very fine definition of the
causes of allergic sensitization from a molecular perspec-
tive. Proteomics appears to provide a crucial added value
in the molecular diagnosis of allergy, especially when indi-
vidualized allergens are not available or when identifying
novel allergens [14]. Sensitization to specific allergens
and/or to panallergens or cross-reactive allergens offers
an accurate evaluation of the diagnosis according to the
concepts of cross-reactivity, co-sensitisation and poly-
sensitisation. Taking into account the abovementioned
concepts and in accordance with the sample studied and
the geographical location of the individuals included in
MW 
Figure 1 Allergogram of 22/33 atopic patients sensitized to cockroach crude extracts.
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allergen components belonging to allergenic sources
distributed throughout the North-Central part of Iran
that contribute to the allergen sensitization in these pa-
tients. Major allergens implicated in the sensitization of
the studied asthmatic population were the Salsola kali
major allergen Sal k 1 (71% prevalence), the grass major
allergen groups 1 and 5 (18% prevalence), the cat major
allergen Fel d 1 (10%), the Artemisia vulgaris major al-
lergen Art v 1 (7.6% prevalence) and the Olea europaea
major allergen Ole e 1 (7.6% prevalence). Only five asth-
matic patients were sensitized to pollen cross-reactive
allergens (profilins or polcalcins) and the panallergen
tropomyosin, with very low specific IgE values (≤0.5 kU/
L), suggesting that the phenomenon of cross-reactivity
is of little relevance in these patients.
The prevalence of sensitization to Blatella germanica
as an allergenic source was relevant (35%) although the
level of specific IgE was lower compared with the other
sources described above (Sal k1, Phl p 1 + 5, Fel d 1 and
Ole e 1). From the immunoblotting results, 4 different
IgE-binding components (75.0, 53.0, 42.0 and 36.0 kDa)
from cockroach were identified, with sensitivity prevalenceTable 3 Protein identification of Blattella germanica
SDS-PAGE protein 1
Calculated MW 53 kDa
Theorical MW 57.501 kDa
Protein description Alpha amylase










NCBI accession number gi|85002763
Results of Mascot search.rates of 15%, 20%, 17% and 12%, in our atopic patient
population, respectively.
According to WHO guidelines [29], cross-reactivity
between an expressed protein and a known allergen has
to be considered in cases in which there are at least six
contiguous identical amino acids or when a segment of
at least 80 residues shares more than 35% identity at the
amino acid level. Using these guidelines, cockroach argin-
ine kinase (42 kDa) and cockroach alpha-amylase (53 kDa)
were identified. Allergenic molecules homologous to the
identified IgE-binding proteins were used to search the
Allergome and IUIS Allergen Nomenclature databases
(www.allergome.org, www. allergen.org), resulting in the
identification of arginine kinase as the Bla t 9 cockroach
allergen [30]. No homologue to the alpha-amylase cock-
roach allergen has been previously described; therefore, a
novel major allergen from cockroach sensitizing 86.4% of
cockroach-sensitized patients was identified. To test for
cross-reactivity with this novel cockroach allergen, sera
from reactive individuals were tested for their specific IgE
reaction to an available alpha-amylase (Aspergillus oryzae)
allergen and by searching the SDAP to demonstrate that
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to the alpha-amylase superfamily because of its similarity
(six contiguous amino acids) with other alpha-amylase
allergens. We found no cross-reactivity with Aspergillus
oryzae alpha amylase, and BLAST alignments of cock-
roach alpha-amylase with other reported allergenic
alpha-amylases [31] showed limited homology. The SDAP
revealed that alpha-amylase allergens from Blomia tropi-
calis (Blo t 4.0101), Dermatophagoides pteronyssinus (Der
p 4) and Euroglyphus maynei (Eur m 4) have the defined
requirements for cross-reactivity with the Blattella germa-
nica alpha-amylase. However, the lack of IgE reactivity
against Dermatophagoides allergens found in this report
suggests that there is little cross-reactivity between cock-
roach alpha-amylase and alpha-amylase from mites in this
patient population.
The statistical analysis between the prevalence of
sensitization by each allergen in the atopic population
and the level of sensitization as indicated by specific IgE,
suggested that Sal k 1 was the main protein allergen in-
fluencing the development and expression of asthma in
this population. Several studies have reported on the
aeroallergen sensitivity of Iranian patients with asthma
or rhinitis [5-7,32], and they found different prevalence
rates among atopic subjects and different percentages of
allergen sensitization. However, all of these studies agree
that pollen sensitization is the most prevalent and that
Chenopodiaceae, grass and sycamore are the most im-
portant allergenic sources. In the present work, Salsola
kali and grasses were also found to be the most import-
ant allergens, although no sensitizations to major aller-
gens from sycamore were discovered. The prevalence of
pollen sensitization found in this work was 37% of the
total asthmatic population and 82% of the allergen-
sensitized population. The aforementioned authors
[5-7,32] reported that indoor allergens were the second
most common cause of sensitization after pollens. Mite
sensitization ranged from 43% to 18%, and cockroach
sensitization ranged from 11% to 29% [33,34]. In our
study, however, no sensitization to mites was demon-
strated, although the prevalence of cockroach sensitization
was 16% among the total asthmatic population and 35%
among the allergen-sensitized population. Moghtaderi
et al. [35] have reported a mold sensitization prevalence
of 11%, with Aspergillus as the most prevalent source,
followed by Cladosporium, Alternaria, Penicillium and
Rhizopus. In this work we did not find significant
sensitization to major allergens from the fungi Aspergillus
or Alternaria.
Conclusions
Pollen and cockroach were the more relevant allergen
sources in the asthmatic population studied herein, with
the Salsola kali major allergen serving as the main causefor sensitization in the atopic patients suffering asthma.
A new Blattella germanica cockroach allergen (Blattella
alpha amylase 53 kDa) has been identified as a major
allergen of Blattella.
To the best of our knowledge, this is the first study
examining a panel of sensitizing allergens in a popula-
tion of asthmatic patients living in Iran for molecular
diagnostic purposes. Using this methodology, it was pos-
sible to identify new allergens from cockroach that could
sensitize a relevant percentage of this population.
These results indicate that cross-reactivity between
pollens or arthropods do not play any significant role in
the sensitization phenomenon of these patients.
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